Evidence map›Paper›PMID 38188233›Full record

ArticleNeuroprotection (Chichester, England)2023

Attenuation of amyotrophic lateral sclerosis via stem cell and extracellular vesicle therapy: An updated review.

Gavin Lockard, Jonah Gordon, Samantha Schimmel, Bassel El Sayed, Molly Monsour, Svitlana Garbuzova-Davis, Cesar V Borlongan

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuroprotection (Chichester, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Gavin LockardUniversity of South Florida Morsani College of Medicine, Tampa, FL, USA.
Jonah GordonUniversity of South Florida Morsani College of Medicine, Tampa, FL, USA.
Samantha SchimmelUniversity of South Florida Morsani College of Medicine, Tampa, FL, USA.
Bassel El SayedUniversity of South Florida Morsani College of Medicine, Tampa, FL, USA.
Molly MonsourUniversity of South Florida Morsani College of Medicine, Tampa, FL, USA.
Svitlana Garbuzova-DavisDepartment of Neurosurgery and Brain Repair, Center of Excellence for Aging and Brain Repair, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
Cesar V BorlonganDepartment of Neurosurgery and Brain Repair, Center of Excellence for Aging and Brain Repair, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
University of South Florida · US

Funding

Targeting Blood-CNS-Barrier in ALS via Apolipoprotein A1R21NS132576 · NINDS · UNIVERSITY OF SOUTH FLORIDA · PI BORLONGAN, CESARIO V, GARBUZOVA-DAVIS, SVITLANA NICOLAI · 2023 to 2024
$412k
NINDS NIH HHS R21 NS132576
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is a rapidly fatal neurological disease characterized by upper and lower motor neuron degeneration. Though typically idiopathic, familial forms of ALS are commonly comprised of a superoxide dismutase 1 (SOD1) mutation. Basic science frequently utilizes SOD1 models

Indexed as

Amyotrophic lateral sclerosisExtracellular vesicleStem cell

Identifiers

PMID38188233
PMCPMC10766415
OpenAlexW4388869382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.